Multidrug transporter ABCG2/breast cancer resistance protein secretes riboflavin (vitamin B2) into milk

被引:160
作者
van Herwaarden, Antonius E.
Wagenaar, Els
Merino, Gracia
Jonker, Johan W.
Rosing, Hilde
Beijnen, Jos H.
Schinkel, Alfred H.
机构
[1] Netherlands Canc Inst, Div Expt Therapy, NL-1066 CX Amsterdam, Netherlands
[2] Slotervaart Hosp, Dept Pharm & Pharmacol, NL-1066 EC Amsterdam, Netherlands
关键词
D O I
10.1128/MCB.01621-06
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The multidrug transporter breast cancer resistance protein (BCRP/ABCG2) is strongly induced in the mammary gland during pregnancy and lactation. We here demonstrate that BCRP is responsible for pumping riboflavin (vitamin B-2) into milk, thus supplying the young with this important nutrient. In Bcrp1(-/-) mice, milk secretion of riboflavin was reduced > 60-fold compared to that in wild-type mice. Yet, under laboratory conditions, Berp1(-/-) pups showed no riboflavin deficiency due to concomitant milk secretion of its cofactor flavin adenine dinucleotide, which was not affected. Thus, two independent secretion mechanisms supply vitamin B-2 equivalents to milk. BCRP is the first active riboflavin efflux transporter identified in mammals and the first transporter shown to concentrate a vitamin into milk. BCRP activity elsewhere in the body protects against xenotoxins by reducing their absorption and mediating their excretion. Indeed, Bcrp1 activity increased excretion of riboflavin into the intestine and decreased its systemic availability in adult mice. Surprisingly, the paradoxical dual utilization of BCRP as a xenotoxin and a riboflavin pump is evolutionarily conserved among mammals as diverse as mice and humans. This study establishes the principle that an ABC transporter can transport a vitamin into milk and raises the possibility that other vitamins and nutrients are likewise secreted into milk by ABC transporters.
引用
收藏
页码:1247 / 1253
页数:7
相关论文
共 22 条
[1]  
Allen JD, 2002, MOL CANCER THER, V1, P417
[2]  
Bardelmeijer HA, 2000, CLIN CANCER RES, V6, P4416
[3]   Detection of single nucleotide polymorphisms in the ABCG2 gene in a Dutch population [J].
Bosch, TM ;
Kjellberg, LM ;
Bouwers, A ;
Koeleman, BPC ;
Schellens, JHM ;
Beijnen, JH ;
Smits, PHM ;
Meijerman, I .
AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (02) :123-131
[4]   Mechanism of the pharmacokinetic interaction between methotrexate and benzimidazoles:: Potential role for breast cancer resistance protein in clinical drug-drug interactions [J].
Breedveld, P ;
Zelcer, N ;
Pluim, D ;
Sönmezer, Ö ;
Tibben, MM ;
Beijnen, JH ;
Schinkel, AH ;
van Tellingen, O ;
Borst, P ;
Schellens, JHM .
CANCER RESEARCH, 2004, 64 (16) :5804-5811
[5]   Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs [J].
Breedveld, P ;
Beijnen, JH ;
Schellens, JHM .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2006, 27 (01) :17-24
[6]   Identification of a missense mutation in the bovine ABCG2 gene with a major effect on the QTL on chromosome 6 affecting milk yield and composition in Holstein cattle [J].
Cohen-Zinder, M ;
Seroussi, E ;
Larkin, DM ;
Loor, JJ ;
Everts-van der Wind, A ;
Lee, JH ;
Drackley, JK ;
Band, MR ;
Hernandez, AG ;
Shani, M ;
Lewin, HA ;
Weller, JI ;
Ron, M .
GENOME RESEARCH, 2005, 15 (07) :936-944
[7]   Current perspectives on the cellular uptake and trafficking of riboflavin [J].
Foraker, AB ;
Khantwal, CM ;
Swaan, PW .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (11) :1467-1483
[8]   Intestinal flora and endogenous vitamin synthesis [J].
Hill, MJ .
EUROPEAN JOURNAL OF CANCER PREVENTION, 1997, 6 :S43-S45
[9]  
Huang SN, 2000, J PHARMACOL EXP THER, V294, P117
[10]   Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression - A role for BCRP in cellular folate homeostasis [J].
Ifergan, I ;
Shafran, A ;
Jansen, G ;
Hooijberg, JH ;
Scheffer, GL ;
Assaraf, YG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (24) :25527-25534